当前位置:
X-MOL 学术
›
Lancet Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world data
The Lancet Oncology ( IF 41.6 ) Pub Date : 2024-10-28 , DOI: 10.1016/s1470-2045(24)00491-1 Marie Lund PhD, Giulia Corn PhD, Maj-Britt Jensen MSc, Tonny Petersen PhD, Prof Kim Dalhoff DMSc, Prof Bent Ejlertsen DMSc, Prof Lars Køber DMSc, Jan Wohlfahrt DMSc, Prof Mads Melbye DMSc
The Lancet Oncology ( IF 41.6 ) Pub Date : 2024-10-28 , DOI: 10.1016/s1470-2045(24)00491-1 Marie Lund PhD, Giulia Corn PhD, Maj-Britt Jensen MSc, Tonny Petersen PhD, Prof Kim Dalhoff DMSc, Prof Bent Ejlertsen DMSc, Prof Lars Køber DMSc, Jan Wohlfahrt DMSc, Prof Mads Melbye DMSc
For aromatase inhibitor treatment (AIT) in breast cancer, there is an unresolved concern about ischaemic cardiotoxicity. We investigated the association between AIT and ischaemic cardiotoxicity in a prospective cohort of female patients with early breast cancer who received contemporary treatment in Denmark.
中文翻译:
芳香化酶抑制剂在丹麦绝经后早期乳腺癌患者中的缺血性心脏毒性:真实世界数据的队列研究
对于乳腺癌的芳香化酶抑制剂治疗 (AIT),对缺血性心脏毒性的担忧尚未解决。我们调查了 AIT 与在丹麦接受当代治疗的早期乳腺癌女性患者前瞻性队列中的缺血性心脏毒性之间的关联。
更新日期:2024-10-28
中文翻译:
芳香化酶抑制剂在丹麦绝经后早期乳腺癌患者中的缺血性心脏毒性:真实世界数据的队列研究
对于乳腺癌的芳香化酶抑制剂治疗 (AIT),对缺血性心脏毒性的担忧尚未解决。我们调查了 AIT 与在丹麦接受当代治疗的早期乳腺癌女性患者前瞻性队列中的缺血性心脏毒性之间的关联。